Vaccine study supports immune targeting of brain tumors
Thursday, June 16, 2011 - 11:30
in Health & Medicine
An experimental vaccine targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data.